UBU9:XETRA:XETRA-UBS (Irl) plc - S&P 500 UCITS USD A-dis (EUR)

ETF | Others |

Last Closing

USD 88.906

Change

+3.50 (+4.10)%

Market Cap

USD 0.50B

Volume

4.33K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.89 (+1.76%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.28 (+1.72%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.57%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.45 (+1.61%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.73%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.87 (+1.94%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+2.20 (+1.54%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.84 (+1.68%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+3.07 (+3.13%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+23.06 (+4.12%)

USD 80.38B

ETFs Containing UBU9:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.77% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.77% 89% A- 88% B+
Trailing 12 Months  
Capital Gain 34.59% 86% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.59% 86% B+ 85% B
Trailing 5 Years  
Capital Gain 96.62% 95% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 96.62% 95% A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 15.28% 86% B+ 84% B
Dividend Return 15.28% 86% B+ 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.58% 39% F 50% F
Risk Adjusted Return 104.79% 96% N/A 96% N/A
Market Capitalization 0.50B 65% D 57% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.